PRELUDE CAPITAL MANAGEMENT, LLC - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$190,568
-26.8%
58,1000.0%0.01%
-29.4%
Q2 2023$260,288
-7.1%
58,1000.0%0.02%0.0%
Q1 2023$280,042
+54.0%
58,1000.0%0.02%
+88.9%
Q4 2022$181,853
-3.8%
58,1000.0%0.01%
+28.6%
Q3 2022$189,000
-9.6%
58,1000.0%0.01%
+16.7%
Q2 2022$209,000
-12.2%
58,1000.0%0.01%
-14.3%
Q1 2022$238,000
-24.4%
58,1000.0%0.01%
-12.5%
Q4 2021$315,000
-27.3%
58,1000.0%0.01%
-27.3%
Q3 2021$433,000
-25.5%
58,1000.0%0.01%
-35.3%
Q2 2021$581,000
-33.0%
58,1000.0%0.02%
-22.7%
Q1 2021$867,00058,1000.02%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 151,132$807,0001.04%
CM Management, LLC 90,000$489,0000.37%
Greenlight Capital 546,560$2,968,0000.17%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$315,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 50,000$267,0000.01%
Veritable, L.P. 25,064$136,0000.00%
Banque Cantonale Vaudoise 3,000$16,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 20,056$107,0000.00%
MILLENNIUM MANAGEMENT LLC 15,754$84,0000.00%
MORGAN STANLEY 800$4,0000.00%
View complete list of GAIN THERAPEUTICS INC shareholders